Stock Events

Oxford Nanopore Technologies 

GBX107.2
43
-GBX3.4-3.07% Today

Statistics

Day High
113
Day Low
104.2
52W High
279
52W Low
85
Volume
949,538
Avg. Volume
1,637,379
Mkt Cap
917.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10SepConfirmed
Q2 2021
Q4 2021
Q2 2022
Q4 2023
Q1 2024
Next
-9.99
-6.66
-3.33
0
Expected EPS
-5.999585796
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ONT.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.49B
Illumina offers sequencing and array-based solutions for genetic and genomic analysis, competing directly in the DNA sequencing market.
Pacific Biosciences of California
PACB
Mkt Cap457.56M
Pacific Biosciences provides long-read sequencing technologies, directly competing with Oxford Nanopore's long-read sequencing capabilities.
Thermo Fisher Scientific
TMO
Mkt Cap209.21B
Thermo Fisher Scientific offers a range of sequencing solutions and genetic analysis tools, competing in the broader genomics and molecular diagnostics market.
Bio-Rad Laboratories - Ordinary Shares
BIO.B
Mkt Cap8.57B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products, including droplet digital PCR systems, which compete in the genomics space.
Qiagen NV
QGEN
Mkt Cap9.63B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the nucleic acid technology market.
Roche
RHHBY
Mkt Cap200.6B
Roche Holding AG, through its acquisition of GenMark Diagnostics, competes in the next-generation sequencing and molecular diagnostics market.
Agilon Health
AGL
Mkt Cap2.59B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, competing in the life sciences and applied chemical markets for genomics and molecular diagnostics.
Bionano Genomics
BNGO
Mkt Cap43.75M
Bionano Genomics offers the Saphyr system for genome analysis, competing in the structural variation detection and genome mapping space.
Fulgent Genetics
FLGT
Mkt Cap626.91M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genomic and molecular diagnostics markets with a focus on next-generation sequencing.

About

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Show more...
CEO
Dr. Gurdial Singh Sanghera
Employees
1238
Country
GB
ISIN
GB00BP6S8Z30
WKN
000A3C307

Listings